• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Zander Laboratories inks $33M deal to develop brain-computer interface tech

Zander Laboratories inks $33M deal to develop brain-computer interface tech

December 19, 2023 By Sean Whooley

Unsplash brain image for brain-computer interfaces blackrock neurotech
[Image from Milad Fakurian on Unsplash]
Germany-based startup Zander Laboratories signed a contract worth €30 million ($32.9 million) to develop neurotechnological prototypes.

Zander signed the contract with The German Agency for Innovation in Cybersecurity. The deal aims to revolutionize the interaction between humans and machines, plus AI. It could eliminate the need for high-risk brain interventions to control machines.

For this initiative, the startup proposed a project called “Neuroadaptivity for Autonomous Systems” (NAFAS). The project employs a passive brain-computer interface (BCI), allowing users to perform actions without actively imagining them. Zander researchers hope to decode mental states based on brain signals, pinpointing categories transferable to artificial systems.

Ultimately, Zander said it hopes to explore a new generation of machines capable of real-time adaptation to user cognitive and affective states.

“It is our stated goal to redefine the interaction between humans and technology,” said Thorsten Zander, managing director of Zander Labs. “We aspire to systems that can intuitively adapt to the individual user based on their brain activity and to AI applications that learn directly from the human brain.”

More details on the future for Zander Labs

Over the next four years, Zander plans to develop a neurotechnological prototype. It intends for this to extract information from the brain and allow individuals to exchange information with an external system. Through thoughts, users can guide the system to perform a task or acquire new skills.

If successful, the company believes humans and machines can collaborate through the passive BCI. With this technology, they could perform actions, pursue goes and exchange information.

Thorsten Zander highlighted the difference between approaches in the BCI technologies coming out of the U.S. and Europe. He said those out of the U.S. — like Neuralink, Precision Neuro and more — prefer invasive methods. They have more focus on medical applications, Zander added.

The Zander Labs approach opts for non-invasive methods aimed at serving users without restrictions. Thorsten Zander wants to “revolutionize human-machine interaction.”

“The revolution lies in enabling machines to capture and interpret brain data in real-time, providing insight into the current, individual perception and interpretation of the user,” he said. “This allows us to transfer the user’s knowledge, values, and goals into the machine, enabling intuitive interaction.”

Filed Under: Brain-Computer Interface (BCI), Business/Financial News, Funding Roundup, Neurological Tagged With: Zander Laboratories

More recent news

  • Boston Scientific continues to make progress on cyberattack recovery
  • Edwards Lifesciences, Medtronic score CMS win for TAVR
  • Stryker still working through cyberattack after-effects, stock down more than 10% this week
  • Siemens Healthineers completes $44M R&D, manufacturing site expansion
  • Next-gen Apple Watch Ultra 4 includes new health features

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy